Reimbursements
-
Read more »
Over 50 countries have approved Spinraza (nusinersen), but not all have made it available to the patients who need it.
-
Posted: April 24, 2017|Categories: Reimbursements|Tags: orphan drug act , food and drug administration (fda) , emflaza , duchenne muscular dystrophy , drug pricing , deflazacort|Read more »
The latest events surrounding the pricing of a Duchenne muscular dystrophy (DMD) treatment
-
Read more »
The PBS, Australia’s national program responsible for providing subsidised prescriptions, has announced the addition of several new medicines
